President and managing director Chin Keat Chyuan\u2019s abrupt resignation on Aug 21 came as a surprise, particularly as several of the initiatives introduced during his tenure are still being implemented. Moreover, it is understood that his contract had been renewed for another term.<\/p>\n
\u201cChin\u2019s departure will be a loss to the healthcare group. During his tenure, he implemented a few transformation initiatives that propelled the group\u2019s net profit by more than 100% and its share price hit a record high,\u201d an analyst who requested anonymity tells The Edge.<\/p>\n
Chin\u2019s leaving now raises the question of how KPJ will maintain that momentum under new leadership. Analysts say the group\u2019s fundamentals remain intact, but the next managing director will inherit a sizeable execution agenda, led by a RM5 billion capital expenditure plan and the continued rollout of the group\u2019s centres of excellence.<\/p>\n
It is worth noting that KPJ had introduced a long-term incentive plan (LTIP) in January 2025 for eligible employees and executive directors, aimed at tying rewards to longer-term performance and retention. Shareholders had approved an allocation of a maximum of three million LTIP shares to Chin in an extraordinary general meeting on Feb 28, 2025. Three months later, he was awarded 1.05 million LTIP shares, worth about RM3.07 million (based on KPJ\u2019s closing price as at May 7, 2025, of RM2.93). The vesting period of the LTIP shares awarded was up to three years from May 8, 2025.<\/p>\n
\u201cIt would appear that Chin would no longer be entitled to the award,\u201d says the analyst.<\/p>\n
In the announcement filed with Bursa Malaysia, the reason given for his exit was just \u201cto pursue other interests\u201d.<\/p>\n
When contacted, Chin declined to comment and directed The Edge to KPJ\u2019s corporate communications personnel.<\/p>\n
Transformation in the last three years<\/p>\n
Chin joined KPJ in September 2023 after more than two decades at Johnson & Johnson, where he had risen through the ranks to managing director for Malaysia and Brunei. His mandate at KPJ included deriving better returns from the company\u2019s sprawling network and sharpening its specialist offerings.<\/p>\n
Chin had already delivered the first leg of KPJ\u2019s transformation through stronger profitability, tighter cost discipline, portfolio rationalisation and a move into higher-value specialist care. On costs, he saw to centralised procurement across the hospital network, used its scale to negotiate better supplier terms and locked in prices under tender arrangements, generating average annual procurement savings of about RM70 million over the past three years.<\/p>\n The 52-year-old also rationalised underperforming overseas assets, disposing of KPJ Dhaka in Bangladesh and selling the Australian aged care business, while retaining stronger performing assets such as Vejthani Hospital in Thailand. KPJ also began establishing its centres of excellence (COEs) to retain complex cases, raise revenue per bed and strengthen its medical tourism proposition.<\/p>\n The healthcare group\u2019s net profit rose 48% from RM182.65 million in FY2022 (the last full financial year before Chin) to RM270.41 million in FY2023, and almost doubled to RM407.24 million in FY2024. Net profit reached RM365.9 million in FY2025, growing 100.3% from the FY2022 level. Revenue of RM2.87 billion in FY2022 climbed to RM3.42 billion in FY2023, RM3.92 billion in FY2024 and RM4.25 billion in FY2025.<\/p>\n For the first half ended June 30, 2026, net profit increased 24.8% year on year to RM173.6 million while revenue rose 12.9% to RM2.25 billion, thanks to higher inpatient volumes and revenue per inpatient.<\/p>\n The incoming MD will inherit KPJ\u2019s 2026-2030 strategic plan, which was announced in February, and its RM5 billion capital expenditure plan to be rolled out over the next four to five years. The investment is set to add 2,200 beds to KPJ\u2019s network of hospitals, increasing its total bed capacity by more than 50% to about 6,270 beds from 4,070 now.<\/p>\n Chin had told The Edge in an earlier interview that the RM5 billion investment will \u201cprimarily support brownfield expansion across our existing hospitals, including new clinical towers, additional capacity and specialist facilities, while also investing in digital health infrastructure, clinical technologies and other strategic initiatives that support the convergence of AI, genomics and value-based care\u201d.<\/p>\n KPJ, which is 44.36% owned by Johor Corp, currently operates 30 hospitals nationwide with a presence in every state except Terengganu and Melaka.<\/p>\n The group also aims to establish 15 COEs by 2030 and has so far launched three: the Heart & Lung Centre of Excellence at KPJ Johor Specialist Hospital, the Neuroscience & Stroke Centre of Excellence at KPJ Damansara Specialist Hospital 2 in Kuala Lumpur and subsequently the Orthopaedic and Rheumatology COE at KPJ Penang Specialist Hospital.<\/p>\n \u201cWe have already seen some results from the two COEs [Johor Specialist Hospital and Damansara Specialist Hospital 2 in Kuala Lumpur],\u201d says an analyst.<\/p>\n The COEs are also expected to attract more international patients. Medical tourism remains quite underdeveloped at KPJ, contributing only 6.2% to FY2025 revenue, compared with 15% at IHH Healthcare Bhd (KL:IHH<\/a>) and 13.8% at Sunway Healthcare Holdings Bhd (KL:SUNMED<\/a>).<\/p>\n The analysts The Edge spoke to say Chin\u2019s departure could also be felt in KPJ\u2019s preparations for the Diagnosis Related Group (DRG) payment system rollout in 2027.<\/p>\n \u201cAs vice-president of the Association of Private Hospitals of Malaysia, Chin had been closely involved in industry engagement with policymakers on the reform. His successor will now have to continue that engagement [for KPJ] while ensuring the group can protect its margins and adapt to a value-based reimbursement model,\u201d says the first analyst.<\/p>\n \u201cThe new MD will have a role to fulfil not just within KPJ, but within Malaysia\u2019s private healthcare sector as a whole. As the Ministry of Health expands its decanting initiative, which involves outsourcing selected patients from public hospitals to private facilities to ease congestion, the incoming MD will have to work closely with the government on this as part of the broader healthcare reset initiative.\u201d\u00a0<\/p>\n When Chin steps down, chief medical director Professor Datuk Dr Hanafiah Harunarashid will become officer-in-charge from Sept 1 pending the appointment of a permanent president and MD.<\/p>\n Datuk Amiruddin Abdul Satar, a long-time KPJ executive who had risen through the group, served as president and managing director from January 2013 until July 2020. He was succeeded by Ahmad Shahizam Mohd Shariff, who joined KPJ after holding senior leadership roles in the healthcare sector, including at Pantai Holdings and Parkway Pantai, and stepped down in March 2022. Datuk Mohd Shukrie Mohd Salleh, formerly group CEO of Malaysia Airports Holdings Bhd, then took over but lasted only five months, from April to September 2022. Chin was appointed a year later, and with a three-year tenure, became the second-longest serving MD among the four.<\/p>\n Bloomberg data shows that of 18 analysts covering the stock, 13 have a \u201cbuy\u201d recommendation and five a \u201chold\u201d. The consensus 12-month target price is RM3.62.<\/p>\n Some analysts argue that the market had already priced in much of KPJ\u2019s operational improvement before Chin\u2019s departure, particularly after the broader re-rating of Malaysian healthcare stocks surrounding Sunway Healthcare\u2019s listing in March.<\/p>\n \u201cI do think the market overreacted [to news of KPJ\u2019s developments and announcements this year]. Sunway Healthcare has already listed and other players have already been revalued and re-rated. Yet analysts have kept raising their target prices. KPJ\u2019s valuation is already very rich,\u201d says the second analyst.<\/p>\n \u201cChin\u2019s departure from KPJ will likely affect our call. But we will need to assess the incoming MD\u2019s plans first.\u201d\u00a0<\/p>\n Leadership change weighs on KPJ\u2019s share price<\/p>\n Shares of KPJ Healthcare Bhd (KL:KPJ<\/a>) came under selling pressure following the announcement of the resignation of its president and managing director Chin Keat Chyuan on Aug 21, after having headed the group for nearly three years. The healthcare group had informed Bursa Malaysia that Chin was leaving to pursue other interests.<\/p>\n KPJ\u2019s shares, which closed at RM3.13 on Aug 20, plunged over the week to RM2.70 last Friday, valuing the company at RM11.95 billion. An estimated RM1.9 billion was wiped out within days of the announcement.<\/p>\n KPJ\u2019s share price experienced a strong run during Chin\u2019s tenure. From RM1.09 on Sept 1, 2023, when he took over as president and managing director, it climbed as much as 216% to a record high of RM3.50 on April 2, 2026.<\/p>\n The day before the announcement, the Employees Provident Fund (EPF) disposed of 8.55 million shares in KPJ. The shares would have been worth about RM26.76 million, based on KPJ\u2019s Aug 20 closing price of RM3.13.<\/p>\n The fund had been accumulating KPJ shares over the last few months. Based on KPJ\u2019s filings with Bursa, the EPF\u2019s stake in the company peaked at around 902 million shares, equivalent to 20.37% equity interest, on July 8 before it began taking profit.<\/p>\n KPJ\u2019s 2025 annual report lists the EPF as its second largest shareholder with 722.64 million shares, or 16.33% equity interest, as at March 31, 2026, behind Johor Corporation\u2019s total direct and indirect interest of 42.51%. Waqaf An-Nur Corp Bhd \u2014 Johor Corporation\u2019s corporate social responsibility and Islamic endowment arm \u2014 held 6.32%.<\/p>\n Over the week following the announcement of Chin\u2019s exit, the EPF continued to pare down its stake in the healthcare group, leaving it with a balance of 801.98 million shares as at Aug 27.<\/p>\n Also on Aug 21, KPJ announced that Chin had disposed of all 981,500 of his shares in the company for RM3.068 million, bringing his direct interest to zero.<\/p>\n \u201cHe acquired 100,000 shares in his first year, 600,000 shares during the second year, and more subsequently on the open market,\u201d says an analyst. These are not the shares awarded to Chin in May 2025 as part of KPJ\u2019s long-term incentive plan.<\/p>\n \u201cWe do not know where Chin [is going], but his resignation and share sale sent a very negative signal to the market,\u201d the analyst adds.<\/p>\n Read also: Save by subscribing<\/a> to us for P\/S: The Edge is also available on![\"\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/09\/KPJ_20260907035406_vvles9.jpg\"\/)
<\/a><\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/09\/KPJ-2_20260907035546_x3ef95.jpg\"\/)
<\/a><\/p>\n
\n“Letter To The Editor: KPJ\u2019s growth architecture is institutional, built beyond any single chapter”<\/a><\/p>\n
\n your print and\/or
\n digital copy.<\/p>\n
\n Apple’s App Store<\/a> and
\n Android’s Google Play<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"This article first appeared in The Edge Malaysia Weekly on August 31, 2026 – September 6, 2026 KPJ…\n","protected":false},"author":2,"featured_media":884393,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,137,500],"class_list":["post-884392","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-au","tag-australia","tag-health","tag-healthcare"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/884392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=884392"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/884392\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/884393"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=884392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=884392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=884392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}